Loading…
Loading…
First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors
Piha-Paul, Sarina A., Sachdev, Jasgit C., Barve, Minal, LoRusso, Patricia, Szmulewitz, Russell, Patel, Sapna Pradyuman, Lara, Primo N., Chen, Xiaotian, Hu, Beibei, Freise, Kevin J., Modi, Dimple, Sood, Anjla, Hutti, Jessica E., Wolff, Johannes, O'Neil, Bert H.
Published in Clinical cancer research (01.11.2019)
Published in Clinical cancer research (01.11.2019)
Get full text
Journal Article
Loading…
Loading…
First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody–Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors
Maitland, Michael L., Sachdev, Jasgit C., Sharma, Manish R., Moreno, Victor, Boni, Valentina, Kummar, Shivaani, Stringer-Reasor, Erica, Lakhani, Nehal, Moreau, Allison R., Xuan, Dawei, Li, Ray, Powell, Eric L., Jackson-Fisher, Amy, Bowers, Michelle, Alekar, Shilpa, Xin, Xiaohua, Tolcher, Anthony W., Calvo, Emiliano
Published in Clinical cancer research (15.08.2021)
Published in Clinical cancer research (15.08.2021)
Get full text
Journal Article
Loading…
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma
Konstantinopoulos, Panagiotis A, Waggoner, Steven, Vidal, Gregory A, Mita, Monica, Moroney, John W, Holloway, Robert, Van Le, Linda, Sachdev, Jasgit C, Chapman-Davis, Eloise, Colon-Otero, Gerardo, Penson, Richard T, Matulonis, Ursula A, Kim, Young Bae, Moore, Kathleen N, Swisher, Elizabeth M, Färkkilä, Anniina, D'Andrea, Alan, Stringer-Reasor, Erica, Wang, Jing, Buerstatte, Nathan, Arora, Sujata, Graham, Julie R, Bobilev, Dmitri, Dezube, Bruce J, Munster, Pamela
Published in JAMA oncology (01.08.2019)
Published in JAMA oncology (01.08.2019)
Get more information
Journal Article
Loading…
Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study
Ramanathan, Ramesh K., Korn, Ronald L., Raghunand, Natarajan, Sachdev, Jasgit C., Newbold, Ronald G., Jameson, Gayle, Fetterly, Gerald J., Prey, Joshua, Klinz, Stephan G., Kim, Jaeyeon, Cain, Jason, Hendriks, Bart S., Drummond, Daryl C., Bayever, Eliel, Fitzgerald, Jonathan B.
Published in Clinical cancer research (15.07.2017)
Published in Clinical cancer research (15.07.2017)
Get full text
Journal Article
Loading…
Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors
Von Hoff, Daniel D., Mita, Monica M., Ramanathan, Ramesh K., Weiss, Glen J., Mita, Alain C., LoRusso, Patricia M., Burris, Howard A., Hart, Lowell L., Low, Susan C., Parsons, Donald M., Zale, Stephen E., Summa, Jason M., Youssoufian, Hagop, Sachdev, Jasgit C.
Published in Clinical cancer research (01.07.2016)
Published in Clinical cancer research (01.07.2016)
Get full text
Journal Article
Loading…
Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase
Sachdev, Jasgit C., Munster, Pamela, Northfelt, Donald W., Han, Hyo Sook, Ma, Cynthia, Maxwell, Fiona, Wang, Tiffany, Belanger, Bruce, Zhang, Bin, Moore, Yan, Thiagalingam, Arunthathi, Anders, Carey
Published in Breast cancer research and treatment (01.02.2021)
Published in Breast cancer research and treatment (01.02.2021)
Get full text
Journal Article
Loading…
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours
Mahalingam, Devalingam, Patel, Manish R., Sachdev, Jasgit C., Hart, Lowell L., Halama, Niels, Ramanathan, Ramesh K., Sarantopoulos, John, Völkel, Dirk, Youssef, Ashraf, Jong, Floris A., Tsimberidou, Apostolia Maria
Published in British journal of clinical pharmacology (01.09.2020)
Published in British journal of clinical pharmacology (01.09.2020)
Get full text
Journal Article
Loading…
Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors
Munster, Pamela N., Greenstein, Andrew E., Fleming, Gini F., Borazanci, Erkut, Sharma, Manish R., Custodio, Joseph M., Tudor, Iulia Cristina, Pashova, Hristina I., Shepherd, Stacie Peacock, Grauer, Andreas, Sachdev, Jasgit C.
Published in Clinical cancer research (02.08.2022)
Published in Clinical cancer research (02.08.2022)
Get full text
Journal Article
Loading…
Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA -Mutant Cancers
Jhaveri, Komal, Chang, Matthew T., Juric, Dejan, Saura, Cristina, Gambardella, Valentina, Melnyk, Anton, Patel, Manish R., Ribrag, Vincent, Ma, Cynthia X., Aljumaily, Raid, Bedard, Philippe L., Sachdev, Jasgit C., Dunn, Lara, Won, Helen, Bond, John, Jones, Surai, Savage, Heidi M., Scaltriti, Maurizio, Wilson, Timothy R., Wei, Michael C., Hyman, David M.
Published in Clinical cancer research (15.01.2021)
Published in Clinical cancer research (15.01.2021)
Get full text
Journal Article
Loading…
Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors
Patnaik, Amita, Weiss, Glen J., Leonard, John E., Rasco, Drew Warren, Sachdev, Jasgit C., Fisher, Terrence L., Winter, Laurie A., Reilly, Christine, Parker, Robert B., Mutz, Danielle, Blaydorn, Lisa, Tolcher, Anthony W., Zauderer, Maurice, Ramanathan, Ramesh K.
Published in Clinical cancer research (15.02.2016)
Published in Clinical cancer research (15.02.2016)
Get full text
Journal Article
Loading…
Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial
Kalinsky, Kevin, Hong, Fangxin, McCourt, Carolyn K, Sachdev, Jasgit C, Mitchell, Edith P, Zwiebel, James A, Doyle, L Austin, McShane, Lisa M, Li, Shuli, Gray, Robert J, Rubinstein, Larry V, Patton, David, Williams, Paul M, Hamilton, Stanley R, Conley, Barbara A, O'Dwyer, Peter J, Harris, Lyndsay N, Arteaga, Carlos L, Chen, Alice P, Flaherty, Keith T
Published in JAMA oncology (01.02.2021)
Published in JAMA oncology (01.02.2021)
Get more information
Journal Article
Loading…
Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose–escalation phase 1 trial
Patnaik, Amita, Weiss, Glen J., Rasco, Drew W., Blaydorn, Lisa, Mirabella, Amy, Beeram, Murali, Guo, Wei, Lu, Sharon, Danaee, Hadi, McEachern, Kristen, Im, Ellie, Sachdev, Jasgit C.
Published in Cancer chemotherapy and pharmacology (01.01.2022)
Published in Cancer chemotherapy and pharmacology (01.01.2022)
Get full text
Journal Article
Loading…
Does Race Affect Outcomes in Triple Negative Breast Cancer?
Sachdev, Jasgit C., Ahmed, Saira, Mirza, Muhammad M., Farooq, Aamer, Kronish, Lori, Jahanzeb, Mohammad
Published in Breast cancer : basic and clinical research (07.05.2010)
Published in Breast cancer : basic and clinical research (07.05.2010)
Get full text
Journal Article
Loading…
Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy
Dudek, Arkadiusz Z., Liu, Li C., Fischer, James H., Wiley, Elizabeth L., Sachdev, Jasgit C., Bleeker, Jonathan, Hurley, Randolph W., Tonetti, Debra A., Thatcher, Gregory R. J., Venuti, Robert P., O’Regan, Ruth M.
Published in Breast cancer research and treatment (01.10.2020)
Published in Breast cancer research and treatment (01.10.2020)
Get full text
Journal Article
Loading…
Update on Precision Medicine in Breast Cancer
Sachdev, Jasgit C, Sandoval, Ana C, Jahanzeb, Mohammad
Published in Cancer treatment and research (2019)
Published in Cancer treatment and research (2019)
Get more information
Journal Article
Loading…
Caveolin-1: Oncogenic role in breast cancer? Clues from molecular profiling
Feldman, Rebecca, Gatalica, Zoran, Reddy, Sandeep K., Castro, Michael, Sachdev, Jasgit C.
Published in Journal of clinical oncology (01.10.2015)
Published in Journal of clinical oncology (01.10.2015)
Get full text
Journal Article
Loading…
Pretherapy Ferumoxytol-enhanced MRI to Predict Response to Liposomal Irinotecan in Metastatic Breast Cancer
Ravi, Harshan, Arias-Lorza, Andres M., Costello, James R., Han, Hyo Sook, Jeong, Daniel K., Klinz, Stephan G., Sachdev, Jasgit C., Korn, Ronald L., Raghunand, Natarajan
Published in Radiology. Imaging cancer (01.03.2023)
Published in Radiology. Imaging cancer (01.03.2023)
Get full text
Journal Article